Sarepta Therapeutics, Inc. (SRPT)
21.67
-0.53
(-2.39%)
USD |
NASDAQ |
Dec 11, 13:38
Sarepta Therapeutics Free Cash Flow: -401.63M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Arrowhead Pharmaceuticals, Inc. | 156.89M |
| Amgen, Inc. | 11.54B |
| Bristol Myers Squibb Co. | 15.30B |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.37M |
| Cash from Investing (Quarterly) | 232.40M |
| Cash from Financing (Quarterly) | -105.00M |
| Free Cash Flow Per Share (Quarterly) | -0.5549 |
| Free Cash Flow to Equity (Quarterly) | 48.07M |
| Free Cash Flow to Firm (Quarterly) | -48.60M |
| Free Cash Flow Yield | -17.96% |